Amrize (NYSE:AMRZ) Reaches New 1-Year Low on Analyst Downgrade

Amrize Ltd (NYSE:AMRZ)’s share price reached a new 52-week low during mid-day trading on Monday after Oppenheimer lowered their price target on the stock from $62.00 to $55.00. Oppenheimer currently has an outperform rating on the stock. Amrize traded as low as $37.38 and last traded at $38.1590, with a volume of 6161890 shares trading hands. The stock had previously closed at $37.54.

Other research analysts have also recently issued research reports about the stock. Wells Fargo & Company restated an “equal weight” rating and set a $44.00 target price (down from $55.00) on shares of Amrize in a research note on Wednesday, September 9th. William Blair set a $40.00 price objective on Amrize in a research note on Wednesday, September 2nd. Zacks Research cut Amrize from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 19th. Sanford C. Bernstein restated an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Finally, Morgan Stanley set a $63.00 price target on shares of Amrize and gave the stock an “overweight” rating in a research note on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eight have given a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $54.25.

Insider Buying and Selling

In related news, CFO Baris Oran bought 3,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was bought at an average price of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the acquisition, the chief financial officer directly owned 3,000 shares in the company, valued at approximately $142,140. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Jan Jenisch bought 26,000 shares of Amrize stock in a transaction on Wednesday, September 2nd. The stock was purchased at an average price of $42.47 per share, with a total value of $1,104,220.00. Following the completion of the acquisition, the chief executive officer directly owned 1,767,000 shares of the company’s stock, valued at $75,044,490. This represents a 1.49% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 48,983 shares of company stock valued at $2,158,755 over the last ninety days. Company insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Hedge funds and other institutional investors have recently made changes to their positions in the company. Norges Bank purchased a new position in Amrize during the fourth quarter worth approximately $929,333,000. Geode Capital Management LLC lifted its stake in shares of Amrize by 3.4% in the fourth quarter. Geode Capital Management LLC now owns 6,093,012 shares of the company’s stock worth $328,080,000 after buying an additional 198,810 shares in the last quarter. Pictet Asset Management Holding SA grew its stake in Amrize by 4.7% during the 1st quarter. Pictet Asset Management Holding SA now owns 5,216,765 shares of the company’s stock valued at $283,017,000 after acquiring an additional 234,731 shares in the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Amrize by 3.7% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock valued at $263,371,000 after acquiring an additional 171,622 shares during the last quarter. Finally, Vontobel Holding Ltd. lifted its stake in Amrize by 2.3% in the 4th quarter. Vontobel Holding Ltd. now owns 4,598,092 shares of the company’s stock worth $252,450,000 after purchasing an additional 105,511 shares in the last quarter.

Amrize Trading Up 1.8%

The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $21.13 billion, a price-to-earnings ratio of 17.58, a PEG ratio of 1.16 and a beta of 0.04. The company has a fifty day moving average price of $45.98 and a two-hundred day moving average price of $51.55.

Amrize (NYSE:AMRZ) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The business had revenue of $3.49 billion during the quarter. As a group, research analysts forecast that Amrize Ltd will post 2.57 earnings per share for the current fiscal year.

Amrize Announces Dividend

The business also recently declared a dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th were given a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s payout ratio is 20.28%.

About Amrize

Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.